Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of Castle Biosciences stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.45, for a total value of $196,310.40. Following the transaction, the director now owns 22,782 shares in the company, […]
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the first quarter ended March.
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that, for the second year in a row, its chief financial officer, Frank Stokes,.
10.04.2024 - Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that, for the second year in a row, its chief financial officer, Frank Stokes, has been selected as a Top 25 CFO of .
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.